Chronic pain education: past, present, and future of psychedelics for the management of chronic pain
Christopher L. Robinson, Pawan Solanki, S Snyder, Adam Amir, Antje M. Barreveld, Rory Vu Mather, Ivo H. Cerda, Michael Motoc, Harman Chopra, R. Jason Yong, Joel Castellanos, Timothy Furnish, Alan D. Kaye, Vwaire Orhurhu, Trent Emerick
Pain Medicine December 10, 2024 DOI: 10.1093/pm/pnae124 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Commentary Peer reviewed |
|---|---|
| Keywords | Pain medicine Anesthesiology Chronic pain Perioperative Family medicine Surgery |
| Key points | Argues that psychedelics are being increasingly explored for chronic pain, major depressive disorder, and post-traumatic stress disorder, and that legislative changes and FDA recognition are driving renewed interest. Contends that medical education needs to integrate formal training on psychedelics to keep pace with the field. |
Abstract
Known for their capacity to alter perception and consciousness, psychedelics are increasingly being explored for therapeutic applications in treating conditions such chronic pain, major depressive disorder, and post-traumatic stress disorder. 1,2 Despite historical stigmas and legal restrictions, recent changes in legislation and the United States Food and Drug Administration (FDA) recognition are driving renewed interest in these substances. To keep pace with this expanding field, medical education needs to integrate formal training on psychedelics.
Citations in the library
Cites 8
- Single-Dose Psilocybin Treatment for Major Depressive Disorder JAMA August 31, 2023
- Adverse effects of psychedelics: From anecdotes and misinformation to systematic science. Journal of Psychopharmacology February 2, 2022
- Psilocybin desynchronizes the human brain. Nature August 1, 2024
- Pharmacological, neural, and psychological mechanisms underlying psychedelics: a critical review Neuroscience & Biobehavioral Reviews September 1, 2022
- Psychedelics: Where we are now, why we got here, what we must do Neuropharmacology February 21, 2018
and 3 more in the library